MedTrace Logo

Human Ab Response & immunoMONItoring of COVID-19 Patients

NCT04373200 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2023-05-23

No results posted yet for this study

Summary

Prospective, mono centric study on COVID-19 patients with or without acute respiratory distress syndrome (ARDS) to analyse the dynamics of the immune response and to search for biomarkers of evolution

Conditions

  • SARS-CoV-2 Coronavirus
  • Acute Respiratory Distress Syndrome

Interventions

BIOLOGICAL

Blood samples collection

Blood sample collection at Day 1, day 7, day 14 for all patients. At month 4 for 25 survivors COVID-19 patients

OTHER

Saliva collection

Saliva collection at Month 4 for 25 survivors COVID-19 patients

Sponsors & Collaborators

  • Rennes University Hospital

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-25
Primary Completion
2021-03-09
Completion
2021-03-09

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04373200 on ClinicalTrials.gov